Vyome Holdings HIND
NASDAQ HIND
$2.03 -0.01 (-0.49%)
At close: Sep 28, 2026 · 4:00 PM EDT

Vyome Holdings (HIND) Restructuring Costs (2024 - 2025)

Updated

Vyome Holdings' Restructuring Costs was $711,000 in Q2 2025, up 233.8% from $213,000 a year earlier and up 77.8% from the prior quarter.

Analysis

Vyome Holdings (HIND) Restructuring Costs (2024 - 2025) Analysis & Trends

For FY2024, Restructuring Costs at Vyome Holdings came in at $1.02 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Vyome Holdings 14.25 Mn -11.86 Mn 11,658.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 711,000.00
Mar 31, 2025 400,000.00
Jun 30, 2024 213,000.00
API Access

Vyome Holdings Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=HIND&period=max&api_key=YOUR_API_KEY